#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigoid Neoplasm Bulbospinal muscular atrophy congenital Glioblastoma Progressive familial intrahepatic cholestasis Subdural haematoma Malignant fibrous histiocytoma Infantile spasms Anti-HLA antibody test positive Desmoid tumour Myocarditis Oesophageal achalasia Canavan disease Nephropathy Ductal adenocarcinoma of pancreas More trials…

    Learn about Rare Diseases

    Carcinoid syndrome Myelodysplastic syndrome Proteus syndrome – Diagnostics Langerhans cell sarcoma – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Lysosomal storage disorder – Diagnostics Burkitt’s lymphoma – Trials in Disease Kearns-Sayre syndrome – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Myxofibrosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Haloperidol Teclistamab Artemisia Vulgaris (312) Mirtazapine Ioflupane (123I) Pazopanib Nicotinamide Sacituzumab Tirumotecan Camonsertib Cd19-Car_Lenti_Allo Sodium Iodide Atomoxetine Progesterone, Micronised Taplucainium Chloride Fianlimab Mk-2060 Desloratadine Metronidazole Sym025 LTG-001 More therapies…

    Learn about Your Condition

    Cushing's syndrome Myopia Macular oedema Premature rupture of membranes Sleep disorder Post procedural complication Palpitations Splenic marginal zone lymphoma Aortic valve stenosis Bacterial infection Crigler-Najjar syndrome Myofascial pain syndrome Breast cancer Vesicoureteric reflux Nervous system disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-term Safety and Efficacy Study of JR-141 (Pabinafusp Alfa) for Male Patients with Hunter Syndrome (Mucopolysaccharidosis II)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis II
    Investigated Drugs:
    • Pabinafusp Alfa
    France Germany Italy Poland Spain

  • Study on the Effects of Iloprost Trometamol in Patients with Infectious Lung Disease on Mechanical Ventilation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Respiratory failure
    Investigated Drugs:
    • Iloprost Trometamol
    • Sodium Chloride
    Denmark

  • Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 18F-Psma-1007
    • Glucagon
    • Hyoscine Butylbromide
    Sweden

  • Study on Regorafenib with Capecitabine, Cyclophosphamide, and Aspirin for Patients with Metastatic Colorectal Cancer Resistant to Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Regorafenib
    • D,L-Lysine Acetylsalicylate
    France

  • Study Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Trametinib
    France

  • Study on the Safety and Effects of [68Ga]Ga-DPI-4452 and [177Lu]Lu-DPI-4452 in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Clear cell renal cell carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • 177Lu-Dpi-4452
    • 68Ga-Dpi-4452
    • Acetazolamide
    Belgium France
Previous Page
1 … 455 456 457 458 459 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!